Twist Bioscience Corporation Common Stock Earnings Dividend

Twist Bioscience Corporation Common Stock’s revenue jumped 23.24% since last year same period to $118.38Mn in the Q2 2026. On a quarterly growth basis, Twist Bioscience Corporation Common Stock has generated 6.92% jump in its revenue since last 3-months.

Twist Bioscience Corporation Common Stock’s net profit fell -271.9% since last year same period to $-35.05Mn in the Q2 2026. On a quarterly growth basis, Twist Bioscience Corporation Common Stock has generated 20.38% jump in its net profits since last 3-months.

Twist Bioscience Corporation Common Stock’s net profit margin fell -239.49% since last year same period to -29.61% in the Q2 2026. On a quarterly growth basis, Twist Bioscience Corporation Common Stock has generated 25.53% jump in its net profit margins since last 3-months.

Twist Bioscience Corporation Common Stock’s earning per share (EPS) estimates for the current quarter stand at -0.5 - a 5.66% jump from last quarter’s estimates.

Twist Bioscience Corporation Common Stock’s earning per share (EPS) estimates for the current year stand at -0.5.

Twist Bioscience Corporation Common Stock’s earning per share (EPS) fell -19.15% since last year same period to -0.56 in the Q2 2026. This indicates that the Twist Bioscience Corporation Common Stock has generated -19.15% annual rate of fall in its earning per share (EPS) in the last 4 quarters.